Ablaze Pharmaceuticals (Ablaze), a clinical-stage pharmaceutical company, announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. (Yonghe) to develop series of targeted radiopharmaceutical therapy (TRT) products. Under the agreement, Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze from pharmaceutical research and preclinical activities to clinical studies.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!